Tamoxifen acutely relaxes coronary arteries by an endothelium-, nitric oxide-, and estrogen receptor-dependent mechanism

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 2, 2000, Pages 519-523

  Figtree, G A ^a   Webb, C M ^a   Collins, P ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

7ALPHA [9 (4,4,5,5,5 PENTAFLUOROPENTYLSULFINYL)NONYL]ESTRA 1,3,5(10) TRIENE 3,17BETA DIOL; ANTIESTROGEN; CALCIUM; CALCIUM CHLORIDE; DIPOTASSIUM HYDROGEN PHOSPHATE; ESTROGEN RECEPTOR; GLUCOSE; MAGNESIUM SULFATE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; TAMOXIFEN;

ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL REACTIVITY; CALCIUM CELL LEVEL; CONTROLLED STUDY; CORONARY ARTERY; FEMALE; HEART INFARCTION; MALE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE TONE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE RELAXATION;

ANIMAL; BARIUM COMPOUNDS; CALCIUM CHANNEL BLOCKERS; CHLORIDES; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; IN VITRO; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RABBITS; RECEPTORS, ESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; VASODILATION;

EID: 0033771599     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Coronary heart disease in women, randomized clinical trials, HERS and RUTH
2. Sudden fall in breast cancer death rates in England and Wales
3. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen
4. Estrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms
5. Estrogen hits the surface
6. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 Randomised trials involving 31000 recurrences and 24000 deaths among 75000 women
7. Raloxifene acutely relaxes rabbit coronary arteries in vitro by an estrogen receptor- and nitric oxidedependent mechanism
8. Tamoxifen elevates transforming growth factor-beta and suppresses diet-induced formation of lipid lesions in mouse aorta
9. Estrogen receptor β - Getting in on the action?
10. 2+ release induced by thromboxane A2 in porcine coronary artery
11. 2+ in guinea pig isolated cardiac myocytes
12. Endothelium-independent relaxation of rabbit coronary artery by 17 β-estradiol in vitro
13. Acute effect of 17 β-estradiol on rabbit coronary artery contractile responses to endothelin-1
14. Estrogen modulates a large conductance chloride channel in cultured porcine aortic endothelial cells
15. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment
16. Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee
17. The protective effects of estrogen on the cardiovascular system
18. Endothelium independent relaxation of human coronary arteries by 17 β-estradiol in vitro
19. Vascular endothelial cells synthesize nitric oxide from L-arginine
20. Age-related difference in tamoxifen disposition
21. The voltage-dependent block of ATP-sensitive potassium channels of frog skeletal muscle by caesium and barium ions
22. Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation
23. A specific inhibition of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation
24. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo
25. Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen
26. Tamoxifen (estrogen antagonist) inhibits voltage-gated calcium current and contractility in vascular smooth muscle from rats
27. Hormone replacement therapy and the cardiovascular system nonlipid effects
28. Mechanisms of estrogen-induced vasodilation: In vivo studies in canine coronary conductance and resistance arteries
29. A potent specific pure antiestrogen with clinical potential
30. Effects of tamoxifen on oxyhemoglobin-induced cerebral vasoconstriction